Submit Science (ISC)

Updated:Nov 6,2014

International Stroke Conference 2016, Feb. 16-19, 2016

Submit Science

Late-Breaking Science and Ongoing Clinical Trials Abstract Submission is closed.

Abstract Submission Guidelines
Why You Should Submit Your Science to the World's Premier Stroke Meeting

The American Heart Association/American Stroke Association maintains the highest standards for abstract acceptance and program development. The goal is to bring a spectrum of the very best stroke science to ISC - from the most basic research to patient-based studies to large clinical trials. The science covers a vast array of topics in 21 categories, including emergency medicine, diagnosis, interventional treatments, nursing and rehabilitation. Submit your best science to the International Stroke Conference 2015.

Submit your Late-Breaking Science and Ongoing Clinical Trials research to the International Stroke Conference - connecting the world to the best stroke science.

Why Submit


Network with International Leaders in the Stroke Field: Attend ISC and discuss your findings with stroke research and practice experts from around the globe. More than 4,000 cerebrovascular experts from 60 countries attend the International Stroke Conference.

International Impact: Media coverage from around the world resulted in almost 1 billion media impressions from more than 1,600 stories for ISC 2014. Impressions from major media outlets included the Associated Press, CBS News, ABC News, Good Morning America, Fox News, The Telegraph, Washington Post, USA Today, LA Times, HealthDay, Cardiology Today, and many more. Social media activities during ISC 2014, including live tweeting on Twitter during the three news conferences, resulted in a total of 1,309 Tweets and 7.4 million impressions. So your research could have global impact.

Virtual Reach: The ISC virtual reach through the AHA/ASA Web site, e-mails, YouTube, Facebook and Twitter activity reached more than 90,000 people daily.

Late-Breaking Science and Ongoing Clinical Trials abstracts will not be published. They will be available online on the International Stroke Conference Web site on February 11, 2015.

A non-refundable $30 processing fee will be required for each abstract submitted. The fee covers administration and online costs associated with the submission, grading, notification and slotting processes.

In order to encourage a broad range of science and speakers, international authors and junior authors are strongly encouraged to submit abstracts for presentation. 

For technical questions, contact the OASIS Helpdesk (opens in new window) or call (217) 398-1792 (Monday - Friday 9 am - 5 pm Central Time).

Late-Breaking Science and Ongoing Clinical Trials Abstract Submission Guidelines:
Rules for Abstract Submission

Ongoing Clinical Trials Abstract Criteria

1. Ongoing Clinical Trials (OGCT) Abstracts Submission is for rationale & design descriptions and eligibility & recruitment updates for clinical trials or large multi-center registries that are currently ongoing.
2. Interim analyses are not eligible for OGCT and should be submitted to the appropriate category in Late-Breaking Science if applicable. (Please see the criteria for Late-Breaking Science Abstract Submission below.)
3. Any abstract submitted as an Ongoing Clinical Trial Abstract that does not fit the criteria above should not be submitted in this category and will not be considered for inclusion in the ISC 2015 program.

Late-Breaking Science Abstract Criteria

1. Late-Breaking Science abstracts should impact future stroke care and treatment. The abstract should focus on unusually important results obtained since the August 12th Scientific Abstract deadline.
2. You must submit an accompanying letter with your abstract; this accompanying letter should ONLY explain why the data was not available prior to the regular submission deadline. This statement must not exceed 100 words. 
3. If the presenter of the Late-Breaking abstract has been selected to participate in an invited symposium where this topic will be covered, they are not eligible to submit a late-breaking abstract.